Australian Investors Podcast, Editor's picks, Podcasts

Investing in ASX biotech ft. Dr Megan Baldwin & Jeremy Curnock Cook

Jeremy Curnock Cook of BioScience Managers and Dr Megan Baldwin of Opthea Ltd (ASX: OPT) join Owen Rask on The Australian Investors Podcast.

Listen to the podcast now

Play Video

Jeremy Curnock Cook is the Managing Director and founder of BioScience Managers, a funds management business specialising in biotechnology investments in Australia and globally. He is also a director of Avita Medical Inc (ASX: AVH). Jeremy joins Owen Rask on The Australian Investors Podcast, alongside Dr Megan Baldwin of Opthea Ltd (ASX: OPT).

Dr Baldwin is one of Australia’s most experienced biotechnology CEOs and holds a PhD in Medicine. Together, Owen, Megan and Jeremy dive deep into what’s included in clinical trials, investing in early, mid and late-stage biotechnology and more.

Opthea & Avita Medical share price

If you this episode, you’ll LOVE our series. Episodes go live every Saturday at 7 am and Wednesday arvo.

We air an interview with an Australian or international investing expert every Wednesday, and Q&A every Saturday! Subscribe below

Podcast resources

SAy g'day to these 👇

The information on this website and in our podcasts is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.

Share this episode:

Search by ticker code:

Stocks mentioned:

AVITA Medical Inc (ASX:AVH), Opthea Ltd (ASX:OPT)

Other episodes:

Matt & Liz Raad on buying websites for 3x profit

Owen’s rant about Woolworths (WOW) & what happens if rates don’t fall?

Netwealth (ASX: NWL) – is a 63x PE too high? SOL is not a LIC & NAB’s new deck chairs

4 ASX ETFs for fast growth, property v shares + how to boost Super by $300,000

Like our podcast? Get weekly newsletter.

Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.

Rask Media

Rask Australia

Important Info

Invest with owen:

General Financial Advice warning

The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.

“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.